abstract |
The disclosures herein relate to novel compounds of Formula (1): and salts thereof, wherein A 1 , A 2 , Q, X, R 1 , R 2 and R 3 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with CGRP receptors. |